China’s VivaVision Biotech Inc. has entered into a partnership with compatriot firm Dragon Sail Pharmaceutical. Under the agreement, Dragon Sail will support VivaVision’s preclinical pharmaceutical research, ranging from sequence to IND filing, with a focus on eye diseases. Financial details of the deal were not disclosed.
Company Profiles
VivaVision is dedicated to research and development in the ophthalmology field, with a product pipeline covering dry eye, glaucoma, uveitis, and other eye conditions. Dragon Sail, established in 2016, is a CDMO / CMO enterprise providing one – stop R & D and production outsourcing services. Its offerings span from sequence to IND, clinical sample production to BLA, and commercial production. The company operates a GMP – compliant manufacturing base in Lingang, Shanghai, with a scale of up to 12,000L.-Fineline Info & Tech
